Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam C Finnefrock

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Immunological Methods|November 20, 2012
Pairwise antibody footprinting using surface plasmon resonance technology to characterize human papillomavirus type 16 virus-like particles with direct anti-HPV antibody immobilizationVictoria Towne, Qinjian Zhao, Martha Brown, et al.
Clinical and Vaccine Immunology : CVI|February 28, 2014
Development of neutralizing monoclonal antibodies for oncogenic human papillomavirus types 31, 33, 45, 52, and 58Martha J Brown, Hanna Seitz, Victoria Towne, et al.
Biophysical Journal|April 20, 2002
Determination of L(alpha)-H(II) phase transition temperature for 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamineGilman E S Toombes, Adam C Finnefrock, Mark W Tate, et al.
Journal of the American Chemical Society|October 23, 2003
The plumber's nightmare: a new morphology in block copolymer-ceramic nanocomposites and mesoporous aluminosilicatesAdam C Finnefrock, Ralph Ulrich, Gilman E S Toombes, et al.
AIDS Research and Human Retroviruses|October 27, 2007
HIV type 1 vaccines for worldwide use: predicting in-clade and cross-clade breadth of immune responsesAdam C Finnefrock, Xiaomei Liu, David W Opalka, et al.
Vaccine|September 6, 2011
A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccinesAimin Tang, Fengsheng Li, Daniel C Freed, et al.
Human Vaccines & Immunotherapeutics|March 18, 2016
Preclinical evaluations of peptide-conjugate vaccines targeting the antigenic domain-2 of glycoprotein B of human cytomegalovirusAdam C Finnefrock, Daniel C Freed, Aimin Tang, et al.
Oncoimmunology|December 18, 2012
An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platformArthur Fridman, Adam C Finnefrock, Daniela Peruzzi, et al.
Vaccine|September 28, 2011
Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infectionDai Wang, Fengsheng Li, Daniel C Freed, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2009
Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adultsMark Wallace, Barbara Evans, Sandra Woods, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Immunological Methods|November 20, 2012
Pairwise antibody footprinting using surface plasmon resonance technology to characterize human papillomavirus type 16 virus-like particles with direct anti-HPV antibody immobilizationVictoria Towne, Qinjian Zhao, Martha Brown, et al.
Clinical and Vaccine Immunology : CVI|February 28, 2014
Development of neutralizing monoclonal antibodies for oncogenic human papillomavirus types 31, 33, 45, 52, and 58Martha J Brown, Hanna Seitz, Victoria Towne, et al.
Biophysical Journal|April 20, 2002
Determination of L(alpha)-H(II) phase transition temperature for 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamineGilman E S Toombes, Adam C Finnefrock, Mark W Tate, et al.
Journal of the American Chemical Society|October 23, 2003
The plumber's nightmare: a new morphology in block copolymer-ceramic nanocomposites and mesoporous aluminosilicatesAdam C Finnefrock, Ralph Ulrich, Gilman E S Toombes, et al.
AIDS Research and Human Retroviruses|October 27, 2007
HIV type 1 vaccines for worldwide use: predicting in-clade and cross-clade breadth of immune responsesAdam C Finnefrock, Xiaomei Liu, David W Opalka, et al.
Vaccine|September 6, 2011
A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccinesAimin Tang, Fengsheng Li, Daniel C Freed, et al.
Human Vaccines & Immunotherapeutics|March 18, 2016
Preclinical evaluations of peptide-conjugate vaccines targeting the antigenic domain-2 of glycoprotein B of human cytomegalovirusAdam C Finnefrock, Daniel C Freed, Aimin Tang, et al.
Oncoimmunology|December 18, 2012
An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platformArthur Fridman, Adam C Finnefrock, Daniela Peruzzi, et al.
Vaccine|September 28, 2011
Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infectionDai Wang, Fengsheng Li, Daniel C Freed, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2009
Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adultsMark Wallace, Barbara Evans, Sandra Woods, et al.
Pageof 3